Top Ranked Momentum Stocks to Buy for August 15th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 15th:
Digital Turbine, Inc. (APPS): This provider of media and mobile communication products and services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 42.9% over the last 60 days.
Digital Turbine, Inc. Price and Consensus
Digital Turbine, Inc. price-consensus-chart | Digital Turbine, Inc. Quote
Digital Turbine'sshares gained 20.7% over the last one month against the S&P 500’s fall of -5.4%. The company possesses a Momentum Score of B.
Digital Turbine, Inc. Price
Digital Turbine, Inc. price | Digital Turbine, Inc. Quote
Alpha and Omega Semiconductor Limited (AOSL): This designer and developer of power semiconductors has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.
Price and Consensus
price-consensus-chart | Quote
Alpha and Omega Semiconductor’s shares gained 21.3% over the last one month. The company possesses a Momentum Score of A.
Alpha and Omega Semiconductor Limited Price
Alpha and Omega Semiconductor Limited price | Alpha and Omega Semiconductor Limited Quote
ACADIA Pharmaceuticals Inc. (ACAD): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote
ACADIA’s shares gained 10.9% over the last one month. The company possesses a Momentum Score of B.
ACADIA Pharmaceuticals Inc. Price
ACADIA Pharmaceuticals Inc. price | ACADIA Pharmaceuticals Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Momentum score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Digital Turbine, Inc. (APPS) : Free Stock Analysis Report
Alpha and Omega Semiconductor Limited (AOSL) : Free Stock Analysis Report
ACADIA Pharmaceuticals Inc. (ACAD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
